BLISS GVS PHARMA LTD.

NSE : BLISSGVSBSE : 506197ISIN CODE : INE416D01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE110.85-1.3 (-1.16 %)
PREV CLOSE ( ) 112.15
OPEN PRICE ( ) 112.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 37025
TODAY'S LOW / HIGH ( )109.10 113.55
52 WK LOW / HIGH ( )71 148.95
NSE110.75-1.45 (-1.29 %)
PREV CLOSE( ) 112.20
OPEN PRICE ( ) 112.25
BID PRICE (QTY) 110.75 (256)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 282005
TODAY'S LOW / HIGH( ) 108.90 114.10
52 WK LOW / HIGH ( )70.85 149.6
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax1060.721277.601041.271289.651819.13
Adjustment579.16-317.09462.91268.50-109.72
Changes In working Capital-851.19733.73-578.86-703.22-1830.73
Cash Flow after changes in Working Capital788.691694.24925.32854.94-121.31
Cash Flow from Operating Activities343.141354.81639.69467.02399.50
Cash Flow from Investing Activities-77.51-929.75-469.91-478.94-735.19
Cash Flow from Financing Activities-249.39-237.30-207.98-63.05168.31
Net Cash Inflow / Outflow16.24187.75-38.20-74.96-167.37
Opening Cash & Cash Equivalents219.87131.35153.40150.37369.50
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANA0.53NA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations13.96-99.2316.1577.47-51.73
Closing Cash & Cash Equivalent250.07219.87131.35153.40150.39

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.